Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
Authors
Keywords
-
Journal
EUROPEAN RESPIRATORY JOURNAL
Volume -, Issue -, Pages 2201347
Publisher
European Respiratory Society (ERS)
Online
2022-08-30
DOI
10.1183/13993003.01347-2022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sotatercept for the Treatment of Pulmonary Arterial Hypertension
- (2021) Marc Humbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
- (2021) Nazzareno Galiè et al. ADVANCES IN THERAPY
- ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
- (2020) Lai-Ming Yung et al. Science Translational Medicine
- Comparisons of global tests on intersection hypotheses and their application in matched parallel gatekeeping procedures
- (2019) John Ouyang et al. Journal of Biopharmaceutical Statistics
- Hematocrit-corrected Pulmonary Vascular Resistance
- (2018) Rebecca R Vanderpool et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial
- (2018) Rami Komrokji et al. Lancet Haematology
- TGFβ and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension
- (2018) Birger Tielemans et al. DRUG DISCOVERY TODAY
- Genetics and genomics of pulmonary arterial hypertension
- (2018) Nicholas W. Morrell et al. EUROPEAN RESPIRATORY JOURNAL
- Risk stratification and medical therapy of pulmonary arterial hypertension
- (2018) Nazzareno Galiè et al. EUROPEAN RESPIRATORY JOURNAL
- Sotatercept, a novel transforming growth factor beta ligand trap, improves anemia in beta-thalassemia: a phase 2, open-label, dose-finding study
- (2018) Maria Domenica Cappellini et al. HAEMATOLOGICA
- Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial
- (2016) Hossein-Ardeschir Ghofrani et al. Lancet Respiratory Medicine
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN HEART JOURNAL
- Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
- (2015) Adaani E. Frost et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Selexipag for the Treatment of Pulmonary Arterial Hypertension
- (2015) Olivier Sitbon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies
- (2015) Haralambos Raftopoulos et al. SUPPORTIVE CARE IN CANCER
- Sotatercept in patients with osteolytic lesions of multiple myeloma
- (2014) Kudrat M. Abdulkadyrov et al. BRITISH JOURNAL OF HAEMATOLOGY
- Riociguat for the Treatment of Pulmonary Arterial Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
- (2012) Raymond L. Benza et al. CHEST
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More